Back to stocks
NSRX
Nasus Pharma Ltd.• Healthcare
Institutional holders
10
As of Q2 2026
Total 13F value
$7.6M
Sum of disclosed positions
New positions
4
This quarter
Sold positions
3
This quarter
Top holders
Institutions with disclosed positions in this stock
| Fund | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. Balyasny Asset Management Llc | $3.1M | 898.5K | 0.00% | Unchanged |
| Cable Car Capital, LP Cable Car Capital Llc | $2.2M | 616.1K | 0.05% | +2.3% |
| Velan Capital Investment Management LP Velan Capital Investment Management Lp | $1.3M | 359.4K | 0.77% | Unchanged |
| Hudson Bay Capital Management LP Hudson Bay Capital Management Lp | $472K | 134.8K | 0.00% | Unchanged |
| Bleichroeder LP Bleichroeder Lp | $314K | 89.8K | 0.06% | Unchanged |
| CITADEL ADVISORS LLC Citadel Advisors | $154K | 44.0K | 0.00% | New Position |
| XTX Topco Ltd Xtx Topco Ltd | $58K | 16.6K | 0.00% | New Position |
| RENAISSANCE TECHNOLOGIES LLC Renaissance Technologies | $43K | 12.2K | 0.00% | New Position |
| MORGAN STANLEY Morgan Stanley | $4K | 1.0K | 0.00% | -50.0% |
| Caitong International Asset Management Co., Ltd Caitong International Asset Management Co., Ltd | $14 | 4 | 0.00% | New Position |